Explore decentralized clinical trials (DCT) and the oversight role of the sponsor. During COVID-19, many trials have been modified and changed to account for the inability to interact with subjects in person and many organizations have moved to a decentralized architecture. Session participants will: understand the regulations pertaining to decentralized clinical trials, learn the perceived benefits and challenges of a DCT, and discuss remote monitoring of DCTs.
Understand the regulations pertaining to decentralized clinical trials.
Learn the perceived benefits and challenges of a DCT.
Discuss remote monitoring of DCTs.
Program Division Director,
U.S. Food and Drug Administration
- ACRP Credits
You must be logged in and own this session in order to